Zinc shows promise as surprising emerging treatment for thrush
New research from the MRC Centre for Medical Mycology could pave the way for the treatment of vaginal yeast infections (thrush).
The research sheds new light on how microbes in the body absorb zinc.
Around three quarters of women develop vaginal yeast infections at least once in their lifetime, and approximately 140 million women globally suffer from recurrent infections.
Recurrent yeast infections can have an enormous impact on quality of life. Existing anti-fungal treatments are not always effective and resistance against these treatments is developing.
What can cause thrush?
Thrush is caused by a yeast called Candida. There are a number of species of Candida, but the one that causes most yeast infections is Candida albicans.
The new research led by the Medical Research Council (MRC) Centre for Medical Mycology at the University of Exeter has found that the trace mineral zinc could play a surprising role.
Just like us, Candida albicans needs zinc in its diet and this yeast produces a molecule (Pra1) which tries to scavenge zinc as a food source.
Now, researchers have found that this molecule triggers an inflammatory response, which they believe is responsible for many cases of thrush.
Urgent need for new treatments
Wellcome Trust Senior Fellow Dr Duncan Wilson at the MRC Centre for Medical Mycology led the research and said:
Recurring thrush can be deeply distressing and problematic, and we urgently need new treatments.
Our new finding on zinc is very exciting, because it suggests that simple provision of zinc could block the production of the inflammatory Pra1 molecule, but we’re not in the position to make treatment recommendations at this stage.
We need larger scale trials to confirm the effect. Please don’t apply any products that are not designed for the genital area, as zinc can be toxic at high concentrations and it could be extremely unsafe.
Prevented inflammation in mice
In lab experiments, the team found that manipulating genes so that Candida albicans does not produce Pra1 prevented inflammation.
They found that applying relatively low levels of zinc in mice blocked Pra1 production and prevented inflammation.
This is important because it is inflammation that causes the burning itching symptoms of thrush.
Encouraging small study in women
The research team also recruited women who had been experiencing vaginal infections at least once every three months.
The women applied a vaginal moisturising cream which contains a small amount of zinc nightly for two weeks, and then twice a week.
Of six women who completed the study and had vaginal yeast infection, five of them did not experience reinfection over the three month study.
Dr Wilson said:
These findings are very encouraging, although the number of participants is small. We are now carrying out a larger clinical trial to confirm that zinc treatments are effective.
In the longer term, we hope this could be a promising strategy for a condition that could evolve resistance to treatment.
10 years of research
We’d been studying this Pra1 molecule for more than ten years to understand its role in zinc scavenging.
This research shows the fundamental importance of basic research of this nature, which can help shed light on how our bodies work and sometimes provide surprising routes to new treatments.
The paper is entitled ‘Zinc prevents vaginal candidiasis by inhibiting expression of an inflammatory fungal protein’ and is published in Science Translational Medicine.
Latest News from
New collaboration seeks to boost UK’s security and resilience01/03/2024 09:10:00
A new research hub combining expertise from government, academia and industry aims to help build a more secure and resilient world.
New public sector innovation programme open for applications29/02/2024 09:10:00
GOTT has launched a new 8-week part-time customer discovery programme for innovators to test whether there is a market for their idea, product or service.
Major future telecoms research boost announced22/02/2024 14:05:00
A major investment of £62 million will help to position the UK to shape the next generation of telecoms networks.
Projects to help communities reduce health inequalities16/02/2024 10:05:00
The mobilising community assets to tackle health inequalities programme aims to improve health through access to culture, nature and community.
New £100m fund will unlock the potential of engineering biology12/02/2024 10:25:00
Six new Engineering Biology Mission Hubs and 22 Mission Awards to transform solutions in areas like vaccine, textile and food production.
Publicly backed bioscience spin-outs make big impact on economy12/02/2024 09:25:00
Hundreds of UK spin-outs, established following taxpayer-funded bioscience research, have contributed £5.2 billion to the economy and created thousands of jobs.
New funding supports UK artists to work with immersive tech01/02/2024 10:10:00
A new project will support over 200 UK-based artists and organisations to explore the creative potential of virtual, augmented and mixed reality technologies.
Researchers uncover mechanism behind stubborn memories22/01/2024 09:10:00
A new study has used the cocaine experience to identify a novel mechanism by which the brain produces powerful lasting memories that drive ill-advised actions.